Company
Acutus Medical
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
24
510(k), De Novo and PMA
Device trials
14
As lead sponsor, any status
Adverse event reports
32
Received Nov 1, 2025 to Nov 20, 2026
Recall records
4
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$292M
8 Form D offerings, 2011 to 2022
Equity
$266M
Stock sold for cash
Debt and convertible notes
$26.3M
$26.3M of it convertible
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: options or warrants, $0 raised of $4.2M sought, first sale Jun 30, 2022, 2 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Jun 30, 2022 | Options or warrants | $0 | $4.2M | 2 | Rule 506(b) | Form D ↗Jul 15, 2022 |
7 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- Acutus Medical, Inc.
- Headquarters
- Carlsbad, California
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1522860 ↗
Executives, directors and promoters
As listed on the latest Form D.
10 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.
The investor database is free with an account
Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.
Latest FDA decisions
The 8 newest of 24 since 2015.
- FlexCath Cross Transseptal SolutionThird-party review510(k)
K233691 · Decided Dec 17, 2023 · 31 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
23 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT04431544 · 513 participants · Start Sep 29, 2020 · Primary completion Nov 8, 2023
Device: AcQMap System · For: Ablation of Arrhythmia's
Sites: Birmingham, Alabama; Phoenix, Arizona; Fullerton, California · 25 sites in all
13 more trials with a free account
Reports received
32
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
3
9.4% of reports
Injury reports
28
88% of reports
Death reports
1
3.1% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 1 | 0 | 0 |
| Feb 24 | 0 | 1 | 0 | 0 |
| Mar 24 | 0 | 2 | 0 | 0 |
| Apr 24 | 0 | 3 | 0 | 0 |
| May 24 | 0 | 2 | 1 | 0 |
| Jun 24 | 0 | 2 | 0 | 0 |
| Jul 24 | 0 | 3 | 0 | 0 |
| Aug 24 | 0 | 1 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 3 | 0 | 0 |
| Nov 24 | 0 | 2 | 1 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 5 | 1 | 0 |
| Feb 25 | 0 | 1 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 1 | 0 | 0 |
| May 25 | 0 | 3 | 0 | 0 |
| Jun 25 | 0 | 3 | 0 | 0 |
| Jul 25 | 0 | 3 | 0 | 0 |
| Aug 25 | 0 | 1 | 0 | 0 |
| Sep 25 | 0 | 1 | 1 | 0 |
| Oct 25 | 2 | 2 | 0 | 0 |
| Nov 25 | 2 | 4 | 0 | 0 |
| Dec 25 | 1 | 2 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 1 | 0 | 0 |
| Mar 26 | 0 | 3 | 0 | 0 |
| Apr 26 | 0 | 3 | 0 | 0 |
| May 26 | 0 | 7 | 0 | 0 |
| Jun 26 | 0 | 4 | 0 | 0 |
| Jul 26 | 0 | 2 | 1 | 0 |
| Aug 26 | 0 | 1 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
The full in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1768-2020 · Started Feb 25, 2020 · Posted by FDA Apr 23, 2020
Reason given: It has been determined that the manufacturing process may have left foreign material particulates on the finished device. This could result in a range of event from procedure delay to pulmonary embolism.
Cause as FDA categorized it: Process design · Device type: Introducer, Catheter (DYB)
3 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.